Nasdaq ctso.

Apr 19, 2023 · About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ... Aug 2, 2023 · As of August 2, 2023, the average one-year price target for Cytosorbents is 8.57. The forecasts range from a low of 5.56 to a high of $16.80. The average price target represents an increase of 155 ... Find the latest Financials data for Cytosorbents Corporation Common Stock (CTSO) at Nasdaq.com. Find the latest SEC Filings data for Cytosorbents Corporation Common Stock (CTSO) at Nasdaq.com.

Cytosorbents Crp stock price (CTSO) NASDAQ: CTSO. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert …Cytosorbents Corp (CTSO) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.The latest price target for CytoSorbents ( NASDAQ: CTSO) was reported by B. Riley Securities on Thursday, September 7, 2023. The analyst firm set a price target for 4.00 expecting CTSO to rise to ...

NASDAQ:CTSO. Cytosorbents (CTSO) Options Chain & Prices $1.34-0.08 (-5.63%) (As of 11/6/2023 ET) Add Compare. Share . Share . Today's Range $1.31 ...About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification.

PRINCETON, N.J., Aug. 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using ...Jul 11, 2023 · About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ... MONMOUTH JUNCTION, N.J., March 29, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb ® blood purification technology ...5 Sep 2023 ... Alexander D'Amico, CFO at CytoSorbents Corporation (Nasdaq: CTSO), a critical care therapy provider, has resigned from his position as part ...

Read Our Latest Report on Cytosorbents. Cytosorbents Stock Performance. NASDAQ CTSO opened at $1.24 on Thursday. The stock has a market cap of $55.11 million, a P/E ratio of -2.34 and a beta of 0.79.

14 Agu 2023 ... PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and ...

Cytosorbents Corporation (NASDAQ: CTSO) Q3 2023 Earnings Call Transcript November 9, 2023 Cytosorbents Corporation misses on earnings …Follow. PRINCETON, N.J., Oct. 27, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac ...Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. About the company. CTSO fundamental analysis. Snowflake Score.CTSO After-Hours Quotes. Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of ...CytoSorbents Stock (NASDAQ:CTSO), Quotes and News Summary. CytoSorbents Stock (NASDAQ: CTSO) stock price, news, charts, stock research, profile. Open 1.220.MONMOUTH JUNCTION, N.J., (PRNewswire) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care ...About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification.

Nov 21, 2023 · The public float for CTSO is 38.46M, and currently, short sellers hold a 4.23% ratio of that floaft. The average trading volume of CTSO on November 21, 2023 was 82.33K shares. CTSO) stock’s latest price update. Cytosorbents Corp (NASDAQ: CTSO)’s stock price has soared by 22.81 in relation to previous closing price of 1.14. Sep 19, 2022 · So spare a thought for the long term shareholders of Cytosorbents Corporation (NASDAQ:CTSO); the share price is down a whopping 78% in the last twelve months. While some investors are willing to ... Earnings Call Transcript Kathleen Bloch NASDAQ:CTSO Phil Chan Q3 2023. Operator: Good afternoon, and welcome to CytoSorbents third quarter 2023 financial and operating results conference call ...By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT CytoSorbents Corporation (NASDAQ:CTSO) is a leader in the treatment of life-threatening conditions in the intensive care unit and ...Apr 19, 2021 · About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, ... Feb 14, 2023 · Cytosorbents Corporation (NASDAQ: CTSO) Cytosorbents Corporation is a medical device company that creates blood purification devices during life-threatening situations. Cytosorbents’ leading product is CytoSorb, an extracorporeal cytokine absorber that helps prevent organ failure, massive inflammation, and patient death.

About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ...Jul 11, 2023 · About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood ...

PRINCETON, N.J., Oct. 12, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...CTSO Latest Pre Market Trades. Select time range to see more trades: Last 100 Trades. Pre-Market Time (ET) Pre-Market Price. Pre-Market Share Volume. 08:27:28. $1.47. 6.5 Sep 2023 ... Alexander D'Amico, CFO at CytoSorbents Corporation (Nasdaq: CTSO), a critical care therapy provider, has resigned from his position as part ...Cytosorbents (CTSO) Earnings Date, Estimates & Call Transcripts $1.17 -0.03 (-2.50%) (As of 12/1/2023 ET) Compare Today's Range $1.17 $1.21 50-Day Range $1.10 …Cytosorbents (NASDAQ:CTSO) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway Jan 10. Health Canada Authorizes CytoSorb for Use in Hospitalized Covid-19 Patients Jan 05. CytoSorbents Promotes Dr. Christian Steiner to Executive Vice President of Sales and MarketingAbout CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification.CTSO CytoSorbents Corporation Form 4 - Statement of changes in beneficial ownership of securities SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange Ac...Cytosorbents Corporation (NASDAQ:CTSO) Q3 2023 Earnings Call Transcript November 9, 2023 Cytosorbents Corporation misses on earnings expectations. Reported EPS is $ …Find the latest Financials data for Cytosorbents Corporation Common Stock (CTSO) at Nasdaq.com.

According to the issued ratings of 2 analysts in the last year, the consensus rating for Cytosorbents stock is Buy based on the current 2 buy ratings for CTSO. The average twelve-month price prediction for Cytosorbents is $4.75 with a high price target of $5.50 and a low price target of $4.00. Learn more on CTSO's analyst rating history.

PRINCETON, N.J., Aug. 14, 2023 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO ), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood ...

Nov 14, 2023 · CytoSorbents (NASDAQ:CTSO) reported 3rd quarter 2023 results on November 9th which showed strong product revenue growth. 3rd quarter product revenues increased 20% to $7.8 million and grant income ... May 2, 2022 · About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification. Find the latest Financials data for Cytosorbents Corporation Common Stock (CTSO) at Nasdaq.com.About Real-Time Quotes. Nasdaq provides NLS Volume, Previous Close, Today's High & Low, and the 52 week High & Low. The intraday chart, the last-five real-time quotes and sales data. Real-time ...Nov 18, 2023 · Cytosorbents Co. (NASDAQ:CTSO – Free Report) – Stock analysts at Zacks Small Cap decreased their FY2023 EPS estimates for shares of Cytosorbents in a research report issued to clients and investors on Tuesday, November 14th. Zacks Small Cap analyst T. Kerr now expects that the medical research company will post earnings of ($0.61) per share […] Cytosorbents Corp (NASDAQ:CTSO) is not the most popular stock in this group but hedge fund interest is still above average. Our overall hedge fund sentiment score for CTSO is 81.9. Stocks with ...According to the issued ratings of 2 analysts in the last year, the consensus rating for Cytosorbents stock is Buy based on the current 2 buy ratings for CTSO. The average twelve-month price prediction for Cytosorbents is $4.75 with a high price target of $5.50 and a low price target of $4.00. Learn more on CTSO's analyst rating history.By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT CytoSorbents (NASDAQ:CTSO) reported 3rd quarter 2023 results on November 9th which showed strong product revenue growth. 3rd ...About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, ...02 Jun, 2022, 07:00 ET. PRINCETON, N.J., June 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO ), a leader in the treatment of life-threatening conditions in the intensive care unit ...

Follow. PRINCETON, N.J., Oct. 27, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac ...Cytosorbents Co. ( NASDAQ:CTSO – Free Report) – B. Riley reduced their FY2023 earnings per share estimates for Cytosorbents in a research note issued on Thursday, November 16th. B. Riley analyst Y. Zhi now expects that the medical research company will post earnings per share of ($0.62) for the year, down from their prior forecast of ($0.57 ...CTSO Latest Pre Market Trades. Select time range to see more trades: Last 100 Trades. Pre-Market Time (ET) Pre-Market Price. Pre-Market Share Volume. 08:27:28. $1.47. 6.Instagram:https://instagram. snow nysewhat is robinhood 24 hour tradingwhere do you buy otc stocksia stock About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification.PRINCETON, N.J., Aug. 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using ... artificial intelligence trading softwarergld stock price Cytosorbents Corporation (CTSO) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 1.2786 +0.0186 (+1.48%) As of 12:02PM EST. Market open. 1d … cheapest motorcycle insurance in california PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT CytoSorbents Corporation (NASDAQ:CTSO) is a leader in the treatment of life-threatening conditions in the intensive care unit and ...(RTTNews) - CytoSorbents Corp. (CTSO), which provides the treatment of life-threatening conditions in intensive care and cardiac surgery using CytoSorb blood purification, made additional comments ...